Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 67544-657, Hydralazine Hydrochloride, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
67544-657
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA088467
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67544-657 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
67544-657-606754406576090 TABLET in 1 BOTTLE (67544-657-60)
67544-657-8067544065780180 TABLET in 1 BOTTLE (67544-657-80)
67544-657-9267544065792270 TABLET in 1 BOTTLE (67544-657-92)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bfbd5960-ae6b-46f5-adfa-e330d7a21dfa

Use it

Look up 67544-657 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67544-657 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67544-657. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.